ライブ

IlluminaIllumina stock (US4523271090): Corporate Responsibility Report highlights genomics growth drivers - AD HOC NEWS Eli LillyElil Lilly buys a Bay Area Y Combinator alum for up to $202M - The Business Journals PfizerPharma sector doubles down on AI amid hopes of slashing costs, timelines - Reuters FierceBiotechGHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm Eli LillyEli Lilly Acquires Engage Bio | PharmExec - Pharmaceutical Executive Mettler ToledoMettler-Toledo stock (US5926881054): analysts’ targets and earnings keep focus on precision instru - AD HOC NEWS LabCorpLabcorp Launches AI-Powered App to Help Patients Understand Test Results - Clinical Lab Products RevvityRevvity Inc. stock (US76155R1086): investors weigh latest earnings and diagnostics focus - AD HOC NEWS Eli LillyCollaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation - Genetic Engineering and Biotechnology News Clinical OMICsEarly Medical Care Linked to Rapid Gut Microbiome Shifts in Amazonian Indigenous Communities Clinical OMICsAI Shows Value for Breast Cancer Prediction Merck & Co.EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study - TradingView

BioPharma Dive 2026年5月20日

Lilly snaps up Engage to advance non-viral genetic medicines

The acquisition is Lilly’s latest push into genetic medicine, giving it a technology designed to overcome some of the field’s longstanding limitatio...

The acquisition is Lilly’s latest push into genetic medicine, giving it a technology designed to overcome some of the field’s longstanding limitations.